Literature DB >> 22814317

Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.

Scott R Dalton1, Wells M Chandler, Margaret Abuzeid, Eric W Hossler, Tammie Ferringer, Dirk M Elston, Philip E LeBoit.   

Abstract

Early diagnosis of mycosis fungoides (MF) is one of the most challenging problems in dermatopathology, as the histopathologic features of inflammatory dermatoses and MF may show significant overlap. One criterion used to distinguish early MF (patch stage) from dermatitis, which may be currently underutilized, is the presence of eosinophils. A search was performed for cases with a preoperative diagnosis of MF, cutaneous T-cell lymphoma, or dermatitis, which included 29 cases "diagnostic" for MF, 25 cases "suspicious" for MF, and 55 cases of spongiotic dermatitis. We examined tissue sections blinded to diagnosis to obtain an exact eosinophil count. Twenty-nine cases were diagnostic for MF (12 patch, 9 plaque, and 8 tumor stage). The average eosinophil count for cases diagnostic for patch stage MF was 1 eosinophil in 10 (0.11) sections examined. For plaque MF, there was 1 eosinophil in 5 (0.24) sections examined. All tumor stage MF cases showed abundant eosinophils within each section. Twenty-five cases were suspicious for MF (15 patches, 9 plaques, and 1 folliculotropic). The average eosinophil count for the patch lesions was 1 eosinophil in 4 (0.25) sections examined and 2 eosinophils per section for plaque lesions. Forty-five of 55 cases of spongiotic dermatitis had at least scattered eosinophils (>3) in each section. Twenty-three (47%) had eosinophils around most postcapillary venules. Only 3 of 45 patients (6.6%) with biopsies diagnostic or suspicious for patch or plaque stage MF showed >3 eosinophils per tissue section, whereas 45 of 55 (81.8%) biopsies of spongiotic dermatitis had >3. The presence of eosinophils (>3 per tissue section) is statistically significant in differentiating cases diagnostic or suspicious for patch or plaque stage MF from dermatitis (P < 0.0001). Our data indicate that eosinophils are uncommon in cases of patch and plaque MF. When a pathologist is faced with evaluating a biopsy that lacks some of the criteria used to make the diagnosis of patch stage MF, yet demonstrates >3 eosinophils per tissue section, dermatitis is the likely diagnosis. However, in cases where fewer than 3 eosinophils are present in sections, patch stage MF cannot be excluded.

Entities:  

Mesh:

Year:  2012        PMID: 22814317     DOI: 10.1097/DAD.0b013e31823d921b

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  6 in total

Review 1.  [Mycosis fungoides or inflammatory dermatitis: differential diagnosis between early lymphoma and inflammation in skin biopsies].

Authors:  I Oschlies; W Klapper
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

Review 2.  Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

3.  Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course.

Authors:  David R Pearson; Mayumi Fujita; Whitney A High
Journal:  J Mol Biomark Diagn       Date:  2017-03-02

4.  Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study.

Authors:  Dorothea Terhorst-Molawi; Katharina Lohse; Katharina Ginter; Viktoria Puhl; Martin Metz; Man Hu; Marcus Maurer; Sabine Altrichter
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 5.  Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?

Authors:  Yann Vincent Charli-Joseph; Michelle Gatica-Torres; Laura Beth Pincus
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

6.  Eosinophils in the skin-a red herring masking lymphoma: a case series.

Authors:  Alejandra Jaque; Alexandra Mereniuk; Shachar Sade; Perla Lansang; Kevin Imrie; Neil H Shear
Journal:  SAGE Open Med Case Rep       Date:  2018-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.